Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease

Go back to Resources

A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease

Authors:

Location:

Go back to Resources

Transplant Success and Immunodulating Diets

Go back to Resources

Transplant Success and Immunodulating Diets

Authors:

Location:

Go back to Resources

The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study

Go back to Resources

The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results

Go back to Resources

The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results

Authors:

Location:

Go back to Resources

Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study

Go back to Resources

Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: A NAPRTCS study

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

Go back to Resources

Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis

Go back to Resources

Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis

Authors:

Location:

Go back to Resources

Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report

Go back to Resources

Studies of Pediatric Liver Transplantation (SPLIT): a summary of the 2003 Annual Report

Authors:

Secondary:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax

Go back to Resources

Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Six-month results of the first, prospective, randomized, multi-center kidney transplant study comparing tacrolimus+ Rapamune vs tacrolimus+ MMF combination therapy

Go back to Resources

Six-month results of the first, prospective, randomized, multi-center kidney transplant study comparing tacrolimus+ Rapamune vs tacrolimus+ MMF combination therapy

Authors:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • Current page 144
  • Page 145
  • Page 146
  • Page 147
  • Page 148
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification